Neilesh Shailesh Ghodadra
CIK: 0002089048
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TTRX
Turn Therapeutics Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Ghodadra Neilesh Shailesh
Ghodadra Neilesh Shailesh (SEC CIK 0002089048) files insider reports with the SEC as Chief Medical Officer of Turn Therapeutics Inc. (TTRX).
Signal8 holds 2 ownership filings by Ghodadra Neilesh Shailesh (1 Form 3, 1 Form 4), filed between Oct 7, 2025 and Oct 10, 2025. Those filings report 1 transaction, the latest on Oct 8, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Ghodadra Neilesh Shailesh's filings is in WESTLAKE VILLAGE, CA.
Recent filings by Ghodadra Neilesh Shailesh
- Oct 8, 2025: Grant or award of TTRX shares (Form 4, code A).
Other insiders filing for Turn Therapeutics Inc. (TTRX)
- Dewhurst Martin William, Director
- Gengos Andrew, Director
- GOLDEN ARTHUR F, Director
- Kester Kent Edward, Director
- Burnam Bradley Evan, Chief Executive Officer
- Chaudhary Zuraiz